Omeros Huntington's disease drug gets FDA fast track

Home › Omeros Huntington's disease drug gets FDA fast track

Omeros Corp. said the U.S. Food and Drug Administration has granted fast track status for one of its drugs targeting Huntington's disease.

08.11	Tech giants dominate U.S. streaming platform market
08.11	Warner Bros. Discovery adds 7.2 million DTC subscribers in 3Q 2024
08.11	Polyurea-Based Lining is Key to GRE Pipeline Rehab Project in UAE
08.11	Parents paying over the odds for baby milk, watchdog warns
08.11	Sports fans driving global growth in streaming services
08.11	TiVo OS footprint approaching one million activated Smart TVs
08.11	The Entertainer axes new shops after Budget tax rise
08.11	Hurricane Rafael Graphics
More »

je.st